*Actual product packaging may differ from the image shown.
Tesamorelin / Ipamorelin
Tesamorelin / Ipamorelin is a complementary growth hormone–supporting peptide combination designed to enhance the body’s natural growth hormone production while supporting fat metabolism, recovery, and body composition. Tesamorelin stimulates growth hormone release through the GHRH pathway with a focus on reducing visceral fat, while Ipamorelin enhances growth hormone pulses without significantly affecting cortisol or prolactin levels. Together, this combination provides a more robust and balanced approach to growth hormone pathway support than either peptide alone.
Protocols developed under the clinical direction of Dr. Jonathann Kuo, MD
Select Size:
What happens after checkout
- ①Purchase your treatment
- ②Complete your Qualiphy consultation via email (~3 min)
- ③Licensed provider reviews & approves your prescription
- ④Pharmacy ships within 3–5 days of approval
After checkout, you'll receive an email to complete your telehealth consultation. A licensed provider must approve before your order ships.
Potential benefits may include:
- Stimulates natural growth hormone release and pulsatility
- Helps reduce visceral and stubborn abdominal fat
- Supports lean muscle mass and healthier body composition
- Improves metabolic efficiency and insulin sensitivity
- Enhances recovery from exercise or physical stress
- Supports energy levels, sleep quality, and overall vitality
- Pregnancy or Breastfeeding: Safety has not been established; use is not recommended.
- Active Cancer or Recent Cancer Treatment: Growth hormone–pathway therapies are generally avoided.
- Known Allergy: Avoid use if you have a sensitivity to Tesamorelin, Ipamorelin, or formulation components.
Mild, short-term side effects may occasionally occur, particularly with initial use or higher doses, including:
- Temporary redness, tenderness, or itching at the injection site
- Mild headache or light fatigue as growth hormone signaling adjusts
- Temporary flushing or warmth
- Mild nausea or stomach discomfort
- Increased appetite, especially early in therapy
- Changes in sleep patterns or vivid dreams (often related to growth hormone activity)
These effects are typically mild and resolve as the body adapts. Starting with a lower dose and gradually increasing can help assess tolerance and minimize side effects.
Regular provider check-ins and periodic bloodwork are recommended to monitor response to therapy, including tracking IGF-1 levels, to ensure growth hormone stimulation remains within healthy, physiologic ranges.
For safe and informed use, review the Extension Health Injection Reaction Guide (PDF), which outlines what to expect, how to reduce discomfort, and when to seek medical support.
- Weeks 1-2: Tesamorelin begins stimulating the pituitary gland through the GHRH pathway, while Ipamorelin enhances natural growth hormone pulses without significantly increasing cortisol or prolactin. Early effects are primarily hormonal and metabolic rather than visible. Some patients notice improvements in sleep quality, overnight recovery, or morning energy during this phase.
- Weeks 3–6: As growth hormone signaling becomes more consistent and balanced, the body becomes more efficient at fat metabolism and tissue repair. Patients may begin to notice gradual improvements in body composition, exercise recovery, and energy levels—especially when paired with proper nutrition, regular movement, and strength training.
- Weeks 8–12: With continued use, more noticeable improvements in fat distribution (including visceral fat), lean muscle preservation, metabolic health, and overall vitality may occur. Recovery capacity and physical resilience often improve during this phase. Results tend to be steady and cumulative, making the Tesamorelin / Ipamorelin combination well suited for body recomposition, metabolic optimization, and long-term health rather than rapid or extreme changes.